Title: Blood Culture Test Market Report, Industry Trends, Share, Share, Regional Breakup and Forecast Till 2025
1 Global Blood Culture Test Market Research
Report and Forecast 2020 - 2025
www.imarcgroup.com
Sales_at_imarcgroup.com
1-631-791-1145
2About IMARC
Email sales_at_expertmarketresearch.com
Web www.expertmarketresearch.com
Phone 1-415-325-5166
3What We Do
4REPORT OBJECTIVES Highlight
5Report Description
According to a new report by IMARC Group, the
global blood culture test market grew at a CAGR
of around 9 during 2014-2019. Looking forward,
the market is expected to continue its moderate
growth during the next five years. A blood
culture test is conducted to diagnose bacterial,
fungal, and mycobacterial infections in the
blood. It identifies various microorganisms in
the blood sample and prevents the development of
sepsis. The culture test helps in determining
typical pathogens in the blood and possible ways
to treat them. It utilizes blood culture media,
assay kits, reagents, automated blood culture
systems, and supporting laboratory
equipment. Get a PDF Sample for more detailed
market insights https//www.imarcgroup.com/blood-
culture-test-market/requestsample Market
Trends The sudden outbreak of COVID-19 has
predominantly catalyzed the demand for blood
culture tests to combat disease transmission.
Several medical laboratories, diagnostic centers,
and other healthcare facilities are widely
adopting these tests to identify the presence of
antibodies in the blood and isolate the infected
individuals. The rising geriatric population,
along with the growing consumer health concerns
towards the high prevalence of infectious
diseases, is further bolstering the market
growth. The increasing healthcare expenditures,
along with the growing number of RD activities
in the medical sector, are also proliferating the
growth of the blood culture test market.
6Report Description
- Blood Culture Test Market, Insights on Market
Segmentation - Â Market Segmentation by Testing Method
- Conventional
- Automated
- Market Segmentation by Product
- Consumables
- Instruments
- Software and Services
- Breakup by Technology
- Culture-based Technology
- Molecular Technology
- Proteomic Technology
- Others
7Report Description
- Market Segmentation by Application
- Bacterial Infection
- Fungal Infection
- Mycobacterial Infection
- Breakup by End-User
- Hospital Laboratories
- Reference Laboratories
- Research Laboratories
- Others
- Market Segmentation by Region
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and AfricaÂ
- Â Â Â
- Competitive Landscape
- The report has also analysed the competitive
landscape of the market with some of the key
players being Abbott Laboratories, Beckman
Coulter (Danaher Corporation)BD (Becton,
Dickinson and Company), Biomérieux SA, Bruker
Corporation, Cepheid Inc. (Danaher Corporation),
Luminex Corporation, Merck Group, Siemens
Healthineers AG, Roche Diagnostics, T2
Biosystems, Thermo Fisher Scientific Inc., etc.
8Report Description
- Browse full report with detailed TOC and list of
figures and tables https//www.imarcgroup.com/blo
od-culture-test-market - Browse Related Report By IMARC Group
- Biochips Market https//www.imarcgroup.com/biochi
ps-market - Biological Safety Cabinet Market
https//www.imarcgroup.com/biological-safety-cabin
et-market - Key Questions Answered in This Report
- How has the global blood culture test market
performed so far and how will it perform in the
coming years? - What are the key regional markets?
- What has been the impact of COVID-19 on the
global blood culture test market? - What is the breakup of the market based on the
testing method? - What is the breakup of the market based on the
product? - What is the breakup of the market based on the
technology? - What is the breakup of the market based on the
application? - What is the breakup of the market based on the
end-user? - What are the various stages in the value chain of
the industry?
9Table of Contents
10Table of Contents
1   Preface2   Scope and Methodology   2.1
  Objectives of the Study  2.2 Â
 Stakeholders  2.3   Data Sources   Â
2.3.1   Primary Sources    2.3.2 Â
 Secondary Sources  2.4   Market EstimationÂ
   2.4.1   Bottom-Up Approach    2.4.2 Â
 Top-Down Approach  2.5   Forecasting
Methodology3 Â Â Executive Summary4 Â
 Introduction  4.1   Overview  4.2   Key
Industry Trends5 Â Â Global Blood Culture Test
Market  5.1   Market Overview  5.2 Â
 Market Performance  5.3   Impact of
COVID-19Â Â 5.4 Â Â Market Forecast6 Â Â Market
Breakup by Testing Method  6.1 Â
 Conventional    6.1.1 Market Trends   Â
6.1.2 Market Forecast  6.2   Automated  Â
 6.2.1 Market Trends           Â
11Table of Contents
  6.2.2 Market Forecast7   Market Breakup by
Product  7.1   Consumables    7.1.1
Market Trends    7.1.2 Major Types    Â
  7.1.2.1 Blood Culture Media        Â
7.1.2.1 Aerobic Blood Culture Media      Â
  7.1.2.2 Anaerobic Blood Culture Media    Â
      7.1.2.3 Fungi/Yeast Blood Culture
Media         7.1.2.4 Mycobacteria
Blood Culture Media       7.1.2.2 Assay
Kits and Reagents       7.1.2.3 Blood
Culture Accessories    7.1.3 Market
Forecast  7.2   Instruments    7.2.1
Market Trends    7.2.2 Major Types    Â
  7.2.2.1 Automated Blood Culture Systems  Â
    7.2.2.2 Supporting Laboratory EquipmentÂ
        7.2.2.1 Incubators      Â
  7.2.2.2 Colony Counters          Â
7.2.2.3 Microscopes         7.2.2.4
Gram Stainers    7.2.3 Market Forecast Â
7.3   Software and Services    7.3.1 Market
Trends             Â
12Table of Contents
7.3.2 Market Forecast8 Â Â Market Breakup by
Technology  8.1   Culture-based TechnologyÂ
   8.1.1 Market Trends    8.1.2 Market
Forecast  8.2   Molecular Technology   Â
8.2.1 Market Trends    8.2.2 Major Types Â
     8.2.2.1 Microarray      Â
8.2.2.2 PCRÂ Â Â Â Â Â Â 8.2.2.3 PNA-FISHÂ Â Â
 8.2.2 Market Forecast  8.3   Proteomic
Technology    8.3.1 Market Trends   Â
8.3.2 Market Forecast  8.4   Others   Â
8.4.1 Market Trends    8.4.2 Market
Forecast9   Market Breakup by Application Â
9.1   Bacterial Infection    9.1.1 Market
Trends    9.1.2 Market Forecast  9.2 Â
 Fungal Infection    9.2.1 Market Trends Â
  9.2.2 Market Forecast  9.3 Â
 Mycobacterial Infection            Â
      Â
13Table of Contents
9.3.1 Market Trends    9.3.2 Market
Forecast10   Market Breakup by End-User Â
10.1   Hospital Laboratories    10.1.1
Market Trends    10.1.2 Market Forecast Â
10.2   Reference Laboratories       10.2.1
Market Trends    10.2.2 Market Forecast Â
10.3   Research Laboratories    10.3.1
Market Trends    10.3.2 Market Forecast Â
10.4   Others    10.4.1 Market Trends  Â
 10.4.2 Market Forecast11   Market Breakup by
Region  11.1   North America    11.1.1
United States      11.1.1.1 Market TrendsÂ
     11.1.1.2 Market Forecast    11.1.2
Canada      11.1.2.1 Market Trends   Â
  11.1.2.2 Market Forecast  11.2   Asia
Pacific    11.2.1 China      11.2.1.1
Market Trends    Â
14Table of Contents
 11.2.1.2 Market Forecast    11.2.2 JapanÂ
     11.2.2.1 Market Trends    Â
 11.2.2.2 Market Forecast    11.2.3 IndiaÂ
     11.2.3.1 Market Trends    Â
 11.2.3.2 Market Forecast    11.2.4 South
Korea      11.2.4.1 Market Trends    Â
 11.2.4.2 Market Forecast    11.2.5
Australia      11.2.5.1 Market Trends  Â
   11.2.5.2 Market Forecast    11.2.6
Indonesia      11.2.6.1 Market Trends  Â
   11.2.6.2 Market Forecast    11.2.7
Others      11.2.7.1 Market Trends   Â
  11.2.7.2 Market Forecast  11.3   EuropeÂ
   11.3.1 Germany      11.3.1.1 Market
Trends      11.3.1.2 Market Forecast  Â
 11.3.2 France      11.3.2.1 Market
Trends      11.3.2.2 Market Forecast   Â
15Table of Contents
11.3.3 United Kingdom      11.3.3.1 Market
Trends      11.3.3.2 Market Forecast  Â
 11.3.4 Italy      11.3.4.1 Market
Trends      11.3.4.2 Market Forecast  Â
 11.3.5 Spain      11.3.5.1 Market
Trends      11.3.5.2 Market Forecast  Â
 11.3.6 Russia      11.3.6.1 Market
Trends      11.3.6.2 Market Forecast  Â
 11.3.7 Others      11.3.7.1 Market
Trends      11.3.7.2 Market Forecast Â
11.4   Latin America    11.4.1 Brazil  Â
   11.4.1.1 Market Trends      11.4.1.2
Market Forecast    11.4.2 Mexico    Â
 11.4.2.1 Market Trends      11.4.2.2
Market Forecast    11.4.3 Others    Â
 11.4.3.1 Market Trends      11.4.3.2
Market Forecast  11.5   Middle East and
Africa   Â
16Table of Contents
11.5.1 Market Trends    11.5.2 Market
Breakup by Country    11.5.3 Market
Forecast12   SWOT Analysis  12.1 Â
 Overview  12.2   Strengths  12.3 Â
 Weaknesses  12.4   Opportunities  12.5 Â
 Threats13   Value Chain Analysis14   Porters
Five Forces Analysis  14.1   Overview Â
14.2   Bargaining Power of Buyers  14.3 Â
 Bargaining Power of Suppliers  14.4   Degree
of Competition  14.5   Threat of New
Entrants  14.6   Threat of Substitutes15 Â
 Competitive Landscape  15.1   Market
Structure  15.2   Key Players  15.3 Â
 Profiles of Key Players    15.3.1   Abbott
Laboratories      15.3.1.1 Company
Overview      15.3.1.2 Product Portfolio Â
     15.3.1.3 Financials       15.3.1.4
SWOT Analysis       Â
17Table of Contents
 15.3.2   Beckman Coulter (Danaher
Corporation)Â Â Â Â Â Â 15.3.2.1 Company
Overview      15.3.2.2 Product PortfolioÂ
     15.3.2.3 SWOT Analysis    15.3.3 Â
 BD (Becton, Dickinson and Company)     Â
15.3.3.1 Company Overview      15.3.3.2
Product Portfolio      15.3.3.3
Financials       15.3.3.4 SWOT Analysis Â
  15.3.4   Biomérieux SA      15.3.4.1
Company Overview      15.3.4.2 Product
Portfolio     15.3.5   Bruker CorporationÂ
     15.3.5.1 Company Overview    Â
 15.3.5.2 Product Portfolio      15.3.5.3
Financials       15.3.5.4 SWOT Analysis Â
  15.3.6   Cepheid Inc. (Danaher
Corporation)Â Â Â Â Â Â 15.3.6.1 Company
Overview      15.3.6.2 Product Portfolio Â
   15.3.7   Luminex Corporation     Â
15.3.7.1 Company Overview      15.3.7.2
Product Portfolio      15.3.7.3
Financials       15.3.7.4 SWOT Analysis Â
  15.3.8   Merck Group     Â
18Table of Contents
 15.3.8.1 Company Overview      15.3.8.2
Product Portfolio      15.3.8.3
Financials       15.3.8.4 SWOT Analysis Â
   15.3.9   Siemens Healthineers AG    Â
 15.3.9.1 Company Overview      15.3.9.2
Product Portfolio     15.3.10   Roche
Diagnostics      15.3.10.1 Company
Overview      15.3.10.2 Product PortfolioÂ
   15.3.11   T2 Biosystems     Â
15.3.11.1 Company Overview      15.3.11.2
Product Portfolio     15.3.12   Thermo
Fisher Scientific Inc.      15.3.12.1
Company Overview      15.3.12.2 Product
Portfolio       15.3.12.3 Financials   Â
   15.3.12.4 SWOT Analysis          Â
                          Â
                Â
19Report FAQs
Team Profile
Team Profile
20Team Profile
Growing team of 150 employees with deep market
knowledge
Engineers and Post Graduates Account for 75 of
our Team
Over 1000 Independent Consultants from different
sectors
Talents from some of the top universities
modelling specialists with unmatched expertise in
quantitative research
Individuals with experience in specific
industries and having sound knowledge of targeted
functional areas
Commercial and non-commercial relationships with
some of the top research institutes
21Report FAQs
Words From Client
22We have been working with IMARC Group for over
two years now. I must say that the word
impossible doesnt seems to appear in their
dictionary,. These guys can provide data for any
market in any country. I have been given them
challenging assignments to work upon and have
been quite impressed with their approach and
results. -Global
Procurement Technology Manager Global FMCG Giant
IMARC Group has great domain expertise and
knowledge base provided all the inputs necessary
for us to define the path forward and launch our
diagnostic successfully in the market where other
players were always afraid before investing.
-Vice President Marketing European
Diagnostic Company
We were really impressed with their research
findings on the South India dairy market. The
innovative idea suggested by them have given us
altogether different aspect to look at the
problem. We started with them on small project
but now thinking on doing more strategic project
with them.
-National Manager (Marketing) Indian Diary Giant
Words From Client
IMARC Group helped us with the outsourcing of a
major part of clinical trials to India. In the
beginning we were skeptic of this idea. But the
success achieved from this strategy is driving us
to outsource other verticals of our business to
low cost destinations - Member of Board of
Managing Director Global Pharmaceutical Giant
Working with IMARC Group has been a great
experience. They were able to provide us with a
comprehensive business report on the India
wastewater treatment market. The finding from the
reports are played a major role in our business
strategies and future decision making
-Senior Vice President Major Indian
Effluent Treatment Company
23Report FAQs
Report FAQs
24 Report FAQs
01
02
03
04
05
25 Report FAQs
06
07
08
09
26SOME OF OUR KEY CUSTOMERS